<?xml version="1.0" encoding="UTF-8"?>
<p id="par0025">In September 2012, a novel coronavirus (CoV) called Middle East respiratory syndrome CoV (MERS-CoV), was isolated as the causative agent of a severe pneumonia in several patients in the Middle East [
 <xref rid="bib0005" ref-type="bibr">1</xref>]. Globally, as of May 16, 2014, WHO has been informed of a total of 614 laboratory-confirmed cases of infection with MERS-CoV (including 181 deaths) primarily in the Middle East (Saudi Arabia, Jordan, Qatar, Oman, Kuwait, and the United Arab Emirates), but also in Europe (the UK, France, Italy, Germany, and Greece), North Africa (Tunisia and Egypt), Asia (Malaysia) and the United States of America (
 <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/don/2014_05_16_mers/en/" id="intr0010" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.who.int/csr/don/2014_05_16_mers/en/</ext-link>, 
 <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/coronavirus/mers/" id="intr0015" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.cdc.gov/coronavirus/mers/</ext-link>). This CoV is closely related to severe acute respiratory syndrome CoV (SARS-CoV), an epidemic that was short-lived but alarming in 2002â€“2003 that resulted in approximately 8000 cases and 800 deaths.
</p>
